From: Serum albumin and mortality risk in a hyperendemic area of HCV infection in Japan
Group A | Group B | P value | ||||
---|---|---|---|---|---|---|
Alb < 4.0 g/L | Alb ≥ 4.0 g/L | |||||
n = 17 | n = 52 | |||||
Malignant tumor | HCC | 6 | 66.7% | 3 | 15.8% | 0.01 |
gastric cancer | 2 | 22.2% | 2 | 10.5% | NS | |
prostate cancer | 1 | 11.1% | 0 | 0.0% | NS | |
lung cancer | 0 | 0.0% | 6 | 31.6% | NS | |
colon cancer | 0 | 0.0% | 4 | 21.1% | NS | |
esophageal cancer | 0 | 0.0% | 1 | 5.3% | NS | |
leukemia | 0 | 0.0% | 1 | 5.3% | NS | |
malignant lymphoma | 0 | 0.0% | 1 | 5.3% | NS | |
unknown | 0 | 0.0% | 1 | 5.3% | NS | |
total | 9 | 52.9% | 19 | 36.5% | NS | |
Cerebrovascular disease | 0 | 0.0% | 10 | 19.2% | NS | |
Cardiac disease | 3 | 17.6% | 6 | 11.5% | NS | |
Pneumonia | 3 | 17.6% | 6 | 11.5% | NS | |
Liver disease | 1 | 5.9% | 3 | 5.8% | NS | |
Diabetes mellitus | 0 | 0.0% | 2 | 3.8% | NS | |
Suicide | 0 | 0.0% | 2 | 3.8% | NS | |
Tuberculosis | 0 | 0.0% | 1 | 1.9% | NS | |
Freak accident | 1 | 5.9% | 1 | 1.9% | NS | |
Feebleness of age | 0 | 0.0% | 1 | 1.9% | NS | |
Other | 0 | 0.0% | 1 | 1.9% | NS |